Mead Johnson Nutrition beats by $0.05, reports revs in-line; guides FY15 EPS above consensus, revs in-line
- Reports Q4 (Dec) earnings of $0.78 per share, $0.05 better than the Capital IQ Consensus of $0.73; revenues fell 11.6% year/year to $967 mln vs the $974.46 mln Capital IQ Consensus.
- Co issues guidance for FY15, sees EPS of $3.48-3.60 vs. $3.40 Capital IQ Consensus Estimate; sees FY15 revs of $4.071-4.15 vs. $4.09 bln Capital IQ Consensus Estimate.
- Co repurchased 10.7 mln shares of stock during qtr under an accelerated share repurchase agreement.